Dynamic Technology Lab’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
EC
Dynamic Technology Lab's JAZZ Position: Q3 2025 in Review
Dynamic Technology Lab sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 3,245 shares — an estimated $344K sold.
Dynamic Technology Lab first reported a position in JAZZ in Q2 2014 and held it in 14 quarters. The position peaked at $768K in Q1 2025. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.
- Dynamic Technology Lab reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Dynamic Technology Lab sold 3,245 Jazz Pharmaceuticals shares in Q3 2025, an estimated $344K.
- Dynamic Technology Lab first reported a position in Jazz Pharmaceuticals in Q2 2014 and held it in 14 quarters.
- Dynamic Technology Lab's Jazz Pharmaceuticals position peaked at $768K in Q1 2025.
- 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.
Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.